Clinical Trials Logo

Septal Defect, Atrial clinical trials

View clinical trials related to Septal Defect, Atrial.

Filter by:
  • None
  • Page 1

NCT ID: NCT05025475 Enrolling by invitation - Clinical trials for Foramen Ovale, Patent

Stitch Closure of PFO and Septal Repair (STITCH)

Start date: January 1, 2021
Phase: N/A
Study type: Interventional

STITCH - Prospective Multi-Center Comparative Parallel Concurrent Study of the NobleStitchâ„¢ EL versus FDA approved Amplatzer Occluder device for closure of Patent Foramen Ovale to prevent recurrent ischemic stroke.

NCT ID: NCT04395027 Withdrawn - Clinical trials for Septal Defect, Atrial

Iatrogenic Atrial Septal Defect Study (iASD)

iASD
Start date: May 6, 2020
Phase: Phase 3
Study type: Interventional

This is an open-label, randomized, controlled trial of iatrogenic atrial septal defect closure with the an atrial septal occluder versus usual care observation in patients post-mitral valve intervention requiring large bore transspetal access.

NCT ID: NCT03373929 Enrolling by invitation - Clinical trials for Foramen Ovale, Patent

Stitch Closure of PFO and Septal Repair

STITCH
Start date: November 20, 2017
Phase: N/A
Study type: Interventional

The purpose of the STITCH study is to evaluate closure rates of clinically relevant septal defects, including patent foramen ovale (PFO), Atrial Septal Defects (ASD - less than 1 cm with redundant septal tissue), trans septal puncture sites, repair of Atrial Septal Aneurysm (ASA) and rate of recurrent neurologic embolic events in patients with cryptogenic stroke and PFO.

NCT ID: NCT01711983 Completed - Clinical trials for Septal Defect, Atrial

Safety and Efficacy of the GORE® Septal Occluder to Treat Ostium Secundum Atrial Septal Defects

Start date: October 2012
Phase: N/A
Study type: Interventional

The primary objective of the GORE® Septal Occluder Study is to evaluate the safety and efficacy of the occluder device in the treatment of transcatheter closure of ostium secundum atrial septal defects (ASDs). The data obtained in this study will evaluate this next generation device as compared to outcomes of prior studies conducted with the GORE® HELEX® Septal Occluder.

NCT ID: NCT00581308 Completed - Clinical trials for Septal Defect, Atrial

Long-term Safety Study of the GORE® HELEX® Septal Occluder

Start date: August 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate the long-term safety and efficacy of the GORE® HELEX® Septal Occluder in the treatment of ostium secundum atrial septal defects (ASDs).